- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Bristol-Myers Squibb Co
Add to PortfolioBMY:US
33.0900 USD 0.1000 0.30%As of 20:04:06 ET on 05/25/2012.
Snapshot for Bristol-Myers Squibb Co (BMY)
| Open: | 32.9300 | Day's Range: | 32.9200 - 33.3000 | Volume: | 5,297,571 | Bid: | 33.0900 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 32.9900 | 52wk Range: | 25.6900 - 35.4400 | 1-Yr Rtn: | +21.15% | Ask: | 33.1000 |
Key Statistics for BMY
| Current P/E Ratio (ttm) | 14.4498 |
|---|---|
| Estimated P/E (12/2012) | 16.9345 |
| Earnings Per Share (USD) (ttm) | 2.2900 |
| Est. EPS (USD) (12/2012) | 1.9540 |
| Est. PEG Ratio | 2.1767 |
| Market Cap (M USD) | 55,891.80 |
| Shares Outstanding (M) | 1,689.08 |
| Enterprise Value (M USD) (ttm) | 52,601.80 |
| Enterprise Value/EBITDA (ttm) | 6.81 |
| Price/Book (mrq) | 3.4089 |
| Price/Sale (ttm) | 2.6123 |
| Dividend Indicated Gross Yield | 4.1100 |
| Next Earnings Announcement | 07/27/2012 |
More BMY Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for BMY
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
| James M Cornelius "Jim"Chairman | Lamberto AndreottiChief Executive Officer |
| Louis S SchmuklerPresident:Technical Operations | Giovanni CaforioPresident:US Pharmaceuticals |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page